FDA NDC Directory · JSON-LD · Markdown

Divalproex sodium

NDC 0615-8377 · HUMAN PRESCRIPTION DRUG · TABLET, EXTENDED RELEASE

Labeler / ManufacturerNCS HealthCare of KY, LLC dba Vangard Labs
Marketing categoryAbbreviated NDA (generic) · App ANDA209286
Dosage form / routeTABLET, EXTENDED RELEASE · ORAL
Active ingredientsDIVALPROEX SODIUM (500 mg/1)
Marketing started20200918
Package count1

External sources

Source: openFDA. Public-domain (CC0).